AbbVie is buying a biotech company working on an experimental eczema drug for $10.9 billion

by News Feed Editor | Jun 22, 2026 | Stock Market

Apogee Therapeutics, which is developing a promising atopic dermatitis drug, saw its stock close nearly 47% higher on Monday. Article Attribution | Read More at Article Source

Micron grew by $1 trillion this year. These two wild cards will determine its trajectory.

by News Feed Editor | Jun 22, 2026 | Stock Market

Analysts are watching to see the impact of a new memory-saving technology, as well as the timeline for additional manufacturing capacity. Article Attribution | Read More at Article Source

A flood of oil is set to hit energy markets. Here’s how much crude may be unleashed.

by News Feed Editor | Jun 22, 2026 | Stock Market

Despite a fragile U.S.-Iran cease-fire and fears of an uneven recovery, millions of barrels of crude oil are already lined up over the short term. Article Attribution | Read More at Article Source

Wall Street loves growth stocks — but these 10 ‘losers’ are primed to win

by News Feed Editor | Jun 22, 2026 | Stock Market

Elon Musk’s $1 trillion SpaceX prediction is probably wrong. Contrarian investors are buying these out-of-favor value plays instead. Article Attribution | Read More at Article Source

A 40% market crash is lurking in the IPO pipeline. SpaceX and OpenAI could trigger it.

by News Feed Editor | Jun 22, 2026 | Stock Market

Prior records for U.S. equity issuance came in 1929 and 2000 — and we all know what happened next. Article Attribution | Read More at Article Source

These six fast-growing stocks sit at the cutting edge of space and military technology

by News Feed Editor | Jun 22, 2026 | Stock Market

In the wake of the SpaceX IPO, investors can expect global communications and AI data processing — both via satellites — to be important themes for many years. Article Attribution | Read More at Article Source